RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Colin Goddard, Ph.D., Chief Executive Officer of OSI Pharmaceuticals, Inc., joins a panel addressing leadership issues in changing times at CED’s 18th annual Biotech conference happening February 16 and 17 at the Raleigh Convention Center in Raleigh, N.C. Dr. Goddard, along with a panel of life science CEOs from leading companies in the biotechnology industry, will discuss the new President, the declining economy, the investor marketplace and how these issues affect management’s decision making and their companies moving forward. The panel will be held on February 17 from 9:30 a.m. to 10:30 a.m.
